Jim O’Connor Named General Counsel and Senior Vice President, Strategic Development Announces Renovia

OrthoNext Digital Platform for the JuniOrtho Plating System Receives FDA Clearance

“Together, OrthoNext and the JuniOrtho Plating System provide a complete solution for surgeons looking for a plating system to address the specific demands of advanced deformity and trauma reconstruction of the lower extremities in the pediatric population,” said Orthofix President of Global Orthopedics Paul Gonsalves.

SonarMed, New Pediatric Monitor Alerts Clinicians To Potential Airway Obstructions During Ventilation Launched

"The SonarMed airway monitoring device has revolutionized the way we care for our littlest patients. There is no other device in the world that can tell you where the endotracheal tube is located within the airway continuously in real-time, and whether the tube is obstructed or even partially occluded," said Jamie W. Powers, M.D., MBA, neonatologist at Huntington Hospital in Pasadena, California.

Today Renovia announced the immediate appointment of  Jim O’Connor as General Counsel & Senior Vice President, Strategic Development.

Mr. O’Connor joined Renovia as General Counsel in February 2018 and since then has led the company’s legal, compliance, quality and regulatory functions. In his new role, Mr. O’Connor’s responsibilities will expand to include corporate business development, manufacturing, program management and overseeing Renovia’s finance team. He will also assist in identifying and implementing programs to improve organizational efficiency and execution.

“Jim has shown remarkable judgment and versatility, and has become a key cross-functional leader,” said Marc Beer, Co-Founder, Chairman and Chief Executive Officer of Renovia. “In his Strategic Development role, Jim will partner with the entire Renovia team to develop and implement strategies to maximize return on investments across our technology portfolio. As Renovia continues its growth and prepares for commercial launch of our next-generation digital therapeutics, he will also help drive potential business development and partnership opportunities.”

“I am so fortunate to work with the outstanding, mission-driven teams across Renovia and genuinely honored to take on this broader leadership role,” stated Mr. O’Connor. “I look forward to working closely with Marc and everyone at Renovia as we leverage our pipeline of digital therapeutic and diagnostic devices to help create a new standard of care in women’s health.”

Prior to joining Renovia, Mr. O’Connor worked for 12 years at United Technologies Corp. (UTC), a Fortune 100 company, in legal and business roles of increasing responsibility. Mr. O’Connor began his legal career at Testa, Hurwitz & Thibeault, where his practice focused on securities law, mergers and acquisitions and licensing transactions for private and publicly traded technology companies. Mr. O’Connor received his Bachelor of Arts from Boston College and his Juris Doctor from Cornell Law School in 1999

 

spot_img

DON'T MISS

Subscribe to Medical Device News Magazine here.

Related Articles